Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
Amporn Atsawarungruangkit, Passisd Laoveeravat, Kittichai Promrat · World Journal of Hepatology · 2021
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting over 30% of the United States population. Early patient identification using a simple method is highly desirable. AIM: To create machine learning models for predicting NAFLD in the general United States population. METHODS: , coarse trees) were tested using the testing dataset. RESULTS: = 3235) that met the inclusion criteria. In the training phase, the ensemble of random undersampling (RUS) boosted trees had the highest F1 (0.53). In the testing phase, we compared selective machine learning models and NAFLD indices. Based on F1, the ensemble of RUS boosted trees remained the top performer (accuracy 71.1% and F1 0.56) followed by the fatty liver index (accuracy 68.8% and F1 0.52). A simple model (coarse trees) had an accuracy of 74.9% and an F1 of 0.33. CONCLUSION: Not every machine learning model is complex. Using a simpler model such as coarse trees, we can create an interpretable model for predicting NAFLD with only two predictors: fasting C-peptide and waist circumference. Although the simpler model does not have the best performance, its simplicity is useful in clinical practice.
Cited by 33 works. doi:10.4254/wjh.v13.i10.1417
Authors
References
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
- The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
- Beyond insulin resistance in NASH: TNF-α or adiponectin?
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
- Epidemiology and natural history of non-alcoholic fatty liver disease
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis